In the latter study, in a panel of 54 anti-cancer drugs, vinca alkaloids were ranked as the most prominent inducer of APC maturation; they increased CD40, CD80, CD86, and MHC II expression, triggered IL-1β, IL-6, and IL-12 p40 production, and augmented the capacity to activate T cells. Here, CD80 is linked to cancer.